---
title: "002589.SZ (002589.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002589.SZ/news.md"
symbol: "002589.SZ"
name: "002589.SZ"
parent: "https://longbridge.com/en/quote/002589.SZ.md"
datetime: "2026-03-14T07:41:47.042Z"
locales:
  - [en](https://longbridge.com/en/quote/002589.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002589.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002589.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002589.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002589.SZ/news.md)


# 002589.SZ (002589.SZ) — Related News

### [Yuli Pharmaceutical acquires rights related to Cialis® (Tadalafil) in three new markets in Asia from Eli Lilly](https://longbridge.com/en/news/278805034.md)
*2026-03-12T02:06:28.000Z*
> Eli Lilly announced the acquisition of all rights to Cialis® in Hong Kong, Macau, and South Korea, expanding to 11 Asian

### [Realcan Pharmaceuticals director Li Zhe is relieved from the order of being under investigation](https://longbridge.com/en/news/275847052.md)
*2026-02-13T04:03:06.000Z*
> Realcan announced that on February 13, 2026, the company received the "Notice of Lifting the Order for Supervision" issu

### [Related party short-term trading and betting clauses hanging in the balance! Can Yan'an Pharmaceutical's IPO make it through the second attempt?](https://longbridge.com/en/news/273229060.md)
*2026-01-21T12:12:10.000Z*
> Yan'an Pharmaceutical has once again applied for an IPO on the Beijing Stock Exchange, facing multiple issues related to

### [Yan'an Pharmaceutical makes a second attempt at the Beijing Stock Exchange: performance plummets and previously failed to meet betting conditions, with R&D expense ratio significantly weaker than peers](https://longbridge.com/en/news/272999873.md)
*2026-01-19T00:20:38.000Z*
> Yan'an Pharmaceutical applied for a listing on the Beijing Stock Exchange again in 2025, with Tianfeng Securities as the

### [](https://longbridge.com/en/news/270938822.md)
*2025-12-29T01:50:02.000Z*
> The A-share pharmaceutical commercial sector weakened at the beginning of trading, with SYPM falling over 15%, HRPC drop

### [](https://longbridge.com/en/news/269161264.md)
*2025-12-10T01:37:02.000Z*
> The A-share pharmaceutical commercial sector has seen a short-term decline, with Realcan dropping over 7%, followed by R

### [Surge of Opportunities! The pharmaceutical distribution sector collectively strengthens, Realcan hits the limit up, and multiple stocks rise in confirmation of policy dividend release!](https://longbridge.com/en/news/268524942.md)
*2025-12-04T03:01:34.000Z*
> The pharmaceutical distribution sector saw a short-term surge today, with Realcan hitting the limit up, and multiple sto

### [The pharmaceutical distribution sector sees a short-term surge, with Realcan hitting the limit-up](https://longbridge.com/en/news/268522902.md)
*2025-12-04T02:38:31.000Z*
> The pharmaceutical distribution sector saw a short-term surge, with Realcan hitting the limit up, followed by gains in Y

### [The proportion of influenza-like cases in the north has reached a four-year high, and the A-share influenza concept has surged. How much real benefit is there?](https://longbridge.com/en/news/268355382.md)
*2025-12-03T04:19:15.000Z*
> On December 3rd, influenced by the proportion of northern flu cases reaching a four-year high, A-share flu concept stock

### [The top stock surged over 3 times, the first natural uranium stock is here!](https://longbridge.com/en/news/268349724.md)
*2025-12-03T03:15:04.000Z*
> Today (December 3), the major market indices opened with mixed trends. The Shanghai Composite Index opened slightly lowe